Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension

Despite the advancement of targeted therapy for pulmonary arterial hypertension (PAH), poor prognosis remains a reality. Mesenchymal stem cells (MSCs) are one of the most clinically feasible alternative treatment options. We compared the treatment effects of adipose tissue (AD)-, bone marrow (BD)-,...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Seyeon, Jang, Albert Y., Chae, Sehyun, Choi, Seungbum, Moon, Jeongsik, Kim, Minsu, Spiekerkoetter, Edda, Zamanian, Roham T., Yang, Phillip C., Hwang, Daehee, Byun, Kyunghee, Chung, Wook-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820276/
https://www.ncbi.nlm.nih.gov/pubmed/33479312
http://dx.doi.org/10.1038/s41598-021-81244-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820276/
https://www.ncbi.nlm.nih.gov/pubmed/33479312
http://dx.doi.org/10.1038/s41598-021-81244-1

Ejemplares similares